Status:
COMPLETED
Freeze All Strategy Versus Fresh Embryo Transfer After GnRH Analogue Trigger
Lead Sponsor:
Istituto Clinico Humanitas
Conditions:
Ovarian Hyperstimulation Syndrome
Pregnancy Related
Eligibility:
FEMALE
20-45 years
Brief Summary
Ovarian hyperstimulation syndrome (OHSS) is one of the most dangerous complications of assisted reproduction technology (ART), described in approximatively 3 to 10% of stimulation cycles although an u...
Detailed Description
The main concerns about the trigger with analogue are about obstetric outcomes, since it may increase the Abortion Rate (AR) and reduce the Ongoing Pregnancy Rate (OPR) due to luteal phase deficiency,...
Eligibility Criteria
Inclusion
- patients undergoing ART cycle with antagonist protocol stimulation and trigger with GnRH agonist
- patients are believed at risk of OHSS at time of trigger based on size and number of follicles developed (≥18 follicles with diameter 12 mm at induction).
Exclusion
- hypogonadotropic hypogonadism
- other ART protocols
- any patient that underwent freeze-all strategy in order to perform pre-implantation genetic testing (PGT)
- oncological or deferring motherhood freezing procedures
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
1396 Patients enrolled
Trial Details
Trial ID
NCT05362734
Start Date
January 1 2012
End Date
December 31 2020
Last Update
July 7 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.